Axsome Therapeutics (AXSM) Equity Ratio: 2022-2025
Historic Equity Ratio for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to 0.11.
- Axsome Therapeutics' Equity Ratio fell 33.42% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year decrease of 33.42%. This contributed to the annual value of 0.10 for FY2024, which is 69.11% down from last year.
- According to the latest figures from Q3 2025, Axsome Therapeutics' Equity Ratio is 0.11, which was down 3.55% from 0.11 recorded in Q2 2025.
- Axsome Therapeutics' Equity Ratio's 5-year high stood at 0.46 during Q3 2022, with a 5-year trough of 0.08 in Q2 2022.
- Moreover, its 3-year median value for Equity Ratio was 0.19 (2024), whereas its average is 0.23.
- Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 441.50% in 2023, then slumped by 69.11% in 2024.
- Over the past 4 years, Axsome Therapeutics' Equity Ratio (Quarterly) stood at 0.33 in 2022, then decreased by 1.77% to 0.32 in 2023, then slumped by 69.11% to 0.10 in 2024, then slumped by 33.42% to 0.11 in 2025.
- Its last three reported values are 0.11 in Q3 2025, 0.11 for Q2 2025, and 0.09 during Q1 2025.